breast cancer risk assessmenthigh risk evaluationbreast cancer and high riskfamilial breast cancerbreast cancer preventiongenetic testing for breast cancerThe challenge facing breast centers and physicians in private practice settings across the nation is the identification and intensive management before ...
“When I went in for my mammogram, I had an assessment to determine my risk for developing breast cancer,” Sumner said. “My mammogram looked fine but I found out that my lifetime risk of developing cancer was 44%. I had two aunts with breast cancer, in addition to my mom having be...
Do you know the key aspects of risk assessment and their implications in early breast cancer? Test your knowledge with this quick quiz.
High-risk breast cancer is defined in this volume as a disease with a high probability of dissemination, implying aggressive behavior, presence of micrometastases at diagnosis, resistance to therapy and ultimate recurrence with poor overall survival. This is in contrast to low-risk disease, which i...
Determining the main risk factors and high-risk groups of breast cancer using a predictive model for breast cancer risk assessment in South Korea. Cancer ... PM Vacek,JM Skelly,BM Geller - 《Breast Cancer Research & Treatment》 被引量: 33发表: 2011年 Family History Attributes and Risk Facto...
RISK assessmentCOMPARATIVE studiesGENE expression profilingBREAST tumorsInter-test concordance between the MammaPrint and the EndoPredict tests used to predict the risk of recurrence in breast cancer was evaluated in 94 oestrogen receptor-positive, HER2-negative breast cancers. We correlated histopathological ...
To understand the dynamics that limit use of risk-management options by women at high risk of breast cancer, there is a critical need for research that focuses on patient perspectives. Prior research has left important gaps: exclusion of high-risk women not in risk-related clinical care, exclus...
Methods: Patients with high-risk breast cancer, who had received conventional imaging and FDG-PET/CT, were included. Patients were staged and assigned a treatment after 1) conventional imaging and 2) FDG-PET/CT, both by a multidisciplinary oncology team. Equivocal FDG-PET/CT findings were ...
This is mainly due to the heterogeneity of breast cancer with BRCA1/2 contributing only about 15–20% of the hereditary component.3 Loss of function variants in two genes, RAD51C4 and RAD51D,5 confer a high risk of ovarian cancer; however, their contribution to breast cancer risk is ...
PURPOSE: To evaluate the risk of recurrence in women diagnosed with T1a and T1b, node-negative, human epidermal growth factor receptor 2 (HER2) -positive breast cancer. METHODS: We reviewed 965 T1a,bN0M0 breast cancers diagnosed at our institution between 1990 and 2002. Dedicated breast pathol...